Hunter C. Smith

Insider Reports History

Location
Boston, MA
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Hunter C. Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hunter C. Smith:

Form 4 holding Chief Financial Officer

RHYTHM PHARMACEUTICALS, INC.

Security class
Restricted Stock Units
Shares / value
25,000
Estimated value
$1,132,956
Report date
11 Feb 2026
Price
$57.22
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aeglea BioTherapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
1,950,000
Estimated value
Report date
22 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Hunter C. Smith

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .